Quantbot Technologies LP Bei Gene, Ltd. Transaction History

Quantbot Technologies LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $280,189 - $356,850	1,300 New	1,300 $280,000
Q3 2022 Nov 07, 2022	SELL	$131.8 - $202.24 $349,797 - $536,744	-2,654 Reduced 69.84%	1,146 $154,000
Q2 2022 Aug 09, 2022	BUY	$121.11 - $216.05 $460,218 - $820,990	3,800 New	3,800 $615,000
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $347,984 - $545,076	-1,400 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$249.6 - $403.14 $349,440 - $564,396	1,400 New	1,400 $508,000
Q1 2020 May 13, 2020	SELL	$121.84 - $173.19 $97,472 - $138,552	-800 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$115.78 - $208.34 $92,624 - $166,672	800 New	800 $132,000
Q3 2019 Nov 12, 2019	SELL	$120.61 - $148.29 $68,627 - $84,377	-569 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$113.99 - $146.86 $64,860 - $83,563	569 New	569 $70,000
Q4 2018 Feb 13, 2019	SELL	$107.01 - $175.15 $187,053 - $306,162	-1,748 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$152.62 - $189.66 $701,899 - $872,246	-4,599 Reduced 72.46%	1,748 $301,000
Q2 2018 Aug 13, 2018	BUY	$152.5 - $216.77 $704,397 - $1 Million	4,619 Added 267.3%	6,347 $975,000
Q1 2018 May 11, 2018	BUY	$97.41 - $177.22 $168,324 - $306,236	1,728 New	1,728 $290,000
Q4 2017 Feb 12, 2018	SELL	$79.6 - $114.73 $123,220 - $177,602	-1,548 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$66.19 - $103.46 $102,462 - $160,156	1,548	1,548 $160,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.